11671 related articles for article (PubMed ID: 1383607)
1. Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma.
Barnhill RL; Fandrey K; Levy MA; Mihm MC; Hyman B
Lab Invest; 1992 Sep; 67(3):331-7. PubMed ID: 1383607
[TBL] [Abstract][Full Text] [Related]
2. Regressing thin cutaneous malignant melanomas (< or = 1.0 mm) are associated with angiogenesis.
Barnhill RL; Levy MA
Am J Pathol; 1993 Jul; 143(1):99-104. PubMed ID: 7686347
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic melanocytic nevi.
Sand M; Gambichler T; Sand D; Altmeyer P; Stuecker M; Bechara FG
Eur J Dermatol; 2011; 21(1):18-21. PubMed ID: 21262599
[TBL] [Abstract][Full Text] [Related]
4. Quantification of vascularity in nodular melanoma and Spitz's nevus.
Binder M; Steiner A; Mossbacher U; Hunegnaw M; Wolff K; Pehamberger H
J Cutan Pathol; 1997 May; 24(5):272-7. PubMed ID: 9194579
[TBL] [Abstract][Full Text] [Related]
5. Analysis of melanocytic lesions by DNA image cytometry.
Schmidt B; Weinberg DS; Hollister K; Barnhill RL
Cancer; 1994 Jun; 73(12):2971-7. PubMed ID: 8199994
[TBL] [Abstract][Full Text] [Related]
6. Dysplastic melanocytic nevi: a reproducible histologic definition emphasizing cellular morphology.
Rhodes AR; Mihm MC; Weinstock MA
Mod Pathol; 1989 Jul; 2(4):306-19. PubMed ID: 2762287
[TBL] [Abstract][Full Text] [Related]
7. Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression.
Einspahr JG; Thomas TL; Saboda K; Nickolof BJ; Warneke J; Curiel-Lewandrowski C; Ranger-Moore J; Duckett L; Bangert J; Fruehauf JP; Alberts DS
Cancer; 2007 Dec; 110(11):2519-27. PubMed ID: 17932890
[TBL] [Abstract][Full Text] [Related]
8. Assessment of vascularity in common blue nevi, small/medium congenital nevocellular, common and dysplastic acquired melanocytic nevi and melanomas: a comparative study.
Ioannidis EN; Aroni K; Kavantzas N
Am J Dermatopathol; 2014 Mar; 36(3):217-22. PubMed ID: 24067800
[TBL] [Abstract][Full Text] [Related]
9. Common acquired melanocytic nevi, dysplastic melanocytic nevi and malignant melanomas: an image analysis cytometric study.
Bruijn JA; Berwick M; Mihm MC; Barnhill RL
J Cutan Pathol; 1993 Apr; 20(2):121-5. PubMed ID: 8320355
[TBL] [Abstract][Full Text] [Related]
10. Maspin expression, angiogenesis, prognostic parameters, and outcome in malignant melanoma.
Chua R; Setzer S; Govindarajan B; Sexton D; Cohen C; Arbiser JL
J Am Acad Dermatol; 2009 May; 60(5):758-66. PubMed ID: 19389518
[TBL] [Abstract][Full Text] [Related]
11. Nestin expression in cutaneous melanomas and melanocytic nevi.
Brychtova S; Fiuraskova M; Hlobilková A; Brychta T; Hirnak J
J Cutan Pathol; 2007 May; 34(5):370-5. PubMed ID: 17448190
[TBL] [Abstract][Full Text] [Related]
12. Tumor progression in the human melanocytic system.
Kath R; Rodeck U; Menssen HD; Mancianti ML; Linnenbach AJ; Elder DE; Herlyn M
Anticancer Res; 1989; 9(4):865-72. PubMed ID: 2554787
[TBL] [Abstract][Full Text] [Related]
13. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
14. Nonpigmented dysplastic melanocytic nevi.
Knoell KA; Hendrix JD; Patterson JW; McHargue CA; Wilson BB; Greer KE
Arch Dermatol; 1997 Aug; 133(8):992-4. PubMed ID: 9267246
[TBL] [Abstract][Full Text] [Related]
15. [Angiogenesis and tumor progression in melanoma].
Vacca A; Ria R; Ribatti D; Bruno M; Dammacco F
Recenti Prog Med; 2000 Nov; 91(11):581-7. PubMed ID: 11125952
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor protein and mRNA expression in cutaneous melanocytic tumours.
Miracco C; De Nisi MC; Arcuri F; Cosci E; Pacenti L; Toscano M; Lalinga AV; Biagioli M; Rubegni P; Vatti R; Maellaro E; Del Bello B; Massi D; Luzi P; Tosi P
Int J Oncol; 2006 Feb; 28(2):345-52. PubMed ID: 16391788
[TBL] [Abstract][Full Text] [Related]
17. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
[TBL] [Abstract][Full Text] [Related]
18. Melanocytic lesions of the genital area with attention given to atypical genital nevi.
Ribé A
J Cutan Pathol; 2008 Nov; 35 Suppl 2():24-7. PubMed ID: 18976416
[TBL] [Abstract][Full Text] [Related]
19. Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma.
Massi D; Naldini A; Ardinghi C; Carraro F; Franchi A; Paglierani M; Tarantini F; Ketabchi S; Cirino G; Hollenberg MD; Geppetti P; Santucci M
Hum Pathol; 2005 Jun; 36(6):676-85. PubMed ID: 16021575
[TBL] [Abstract][Full Text] [Related]
20. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]